Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease ; volume:13 ; number:1 ; day:3 ; month:3 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (3.3.2023), 1-8, 12.2023
- Classification
-
Ingenieurwissenschaften und Maschinenbau
- Creator
-
Chung, Goh Eun
Oh, Sohee
Ahn, Dong-Won
Kim, Su Hwan
Jung, Yong Jin
Kim, Ji Won
Kim, Byeong Gwan
Lee, Kook Lae
Jeong, Ji Bong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-30833-3
- URN
-
urn:nbn:de:101:1-2024030410070495419038
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chung, Goh Eun
- Oh, Sohee
- Ahn, Dong-Won
- Kim, Su Hwan
- Jung, Yong Jin
- Kim, Ji Won
- Kim, Byeong Gwan
- Lee, Kook Lae
- Jeong, Ji Bong
- SpringerLink (Online service)
Other Objects (12)
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
Estradiol signaling mediates gender difference in visceral adiposity via autophagy
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
Estradiol signaling mediates gender difference in visceral adiposity via autophagy
Association of visceral adiposity index with sarcopenia based on NHANES data
Visceral adiposity syndrome
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Model containing sarcopenia and visceral adiposity can better predict the prognosis of hepatocellular carcinoma: a multicenter study
The interaction between MALAT1 and TUG1 with dietary fatty acid quality indices on visceral adiposity index and body adiposity index
Visceral adiposity, insulin resistance and cancer risk
Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
Association between visceral adiposity and generalized anxiety disorder (GAD)
Non-alcoholic fatty liver disease
Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis